Harmony Biosciences Holdings Inc’s filing revealed that its CHIEF COMMERCIAL OFFICER Dierks Jeffrey unloaded Company’s shares for reported $0.49 million on Jan 24 ’25. In the deal valued at $37.31 per share,13,125 shares were sold. As a result of this transaction, Dierks Jeffrey now holds 0 shares worth roughly $0.0.
Then, Dierks Jeffrey sold 1,629 shares, generating $61,941 in total proceeds. Upon selling the shares at $38.02, the CHIEF COMMERCIAL OFFICER now owns 0 shares.
Before that, Kapadia Sandip sold 1,775 shares. Harmony Biosciences Holdings Inc shares valued at $67,547 were divested by the CHIEF FINANCIAL OFFICER at a price of $38.05 per share. As a result of the transaction, Kapadia Sandip now holds 0 shares, worth roughly $0.0.
H.C. Wainwright initiated its Harmony Biosciences Holdings Inc [HRMY] rating to a Buy in a research note published on December 17, 2024; the price target was $75. UBS began covering HRMY with “Buy” recommendation on September 10, 2024. Citigroup started covering the stock on June 21, 2024. It rated HRMY as “a Buy”.
Price Performance Review of HRMY
On Monday, Harmony Biosciences Holdings Inc [NASDAQ:HRMY] saw its stock fall -0.18% to $38.70. Over the last five days, the stock has gained 1.18%. Harmony Biosciences Holdings Inc shares have risen nearly 12.47% since the year began. Nevertheless, the stocks have risen 22.70% over the past one year. While a 52-week high of $41.61 was reached on 01/21/25, a 52-week low of $28.14 was recorded on 01/10/25. SMA at 50 days reached $35.29, while 200 days put it at $33.77.
Levels Of Support And Resistance For HRMY Stock
The 24-hour chart illustrates a support level at 37.89, which if violated will result in even more drops to 37.07. On the upside, there is a resistance level at 39.31. A further resistance level may holdings at 39.92. The Relative Strength Index (RSI) on the 14-day chart is 59.99, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.53, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 42.80%. Stochastics %K at 68.30% indicates the stock is a holding.
How much short interest is there in Harmony Biosciences Holdings Inc?
A steep rise in short interest was recorded in Harmony Biosciences Holdings Inc stocks on 2025-01-15, growing by 81884.0 shares to a total of 5.53 million shares. Yahoo Finance data shows the prior-month short interest on 2024-12-13 was 5.44 million shares. There was a rise of 1.48%, which implies that there is a positive sentiment for the stock.
